109 related articles for article (PubMed ID: 10668471)
1. Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis.
Hager JH; Hanahan D
Ann N Y Acad Sci; 1999; 887():150-63. PubMed ID: 10668471
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
3. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X; McCarrick J; Jewett L; Knowles BB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
[TBL] [Abstract][Full Text] [Related]
4. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Memoli VA; Longnecker DS
Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors.
Fendrich V; Rehm J; Waldmann J; Buchholz M; Christofori G; Lauth M; Slater EP; Bartsch DK
Ann Surg; 2011 Mar; 253(3):546-52. PubMed ID: 21239987
[TBL] [Abstract][Full Text] [Related]
6. Transformation of the microvascular system during multistage tumorigenesis.
Ryschich E; Schmidt J; Hämmerling GJ; Klar E; Ganss R
Int J Cancer; 2002 Feb; 97(6):719-25. PubMed ID: 11857345
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes.
Chang I; Cho N; Koh JY; Lee MS
Diabetologia; 2003 Sep; 46(9):1220-7. PubMed ID: 12898018
[TBL] [Abstract][Full Text] [Related]
8. Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs.
Haas MJ; Dragan YP; Hikita H; Shimel R; Takimoto K; Heath S; Vaughan J; Pitot HC
Am J Pathol; 1999 Jul; 155(1):183-92. PubMed ID: 10393850
[TBL] [Abstract][Full Text] [Related]
9. Proliferation, hyperplasia, neogenesis, and neoplasia in the islets of Langerhans.
Ballian N; Hu M; Liu SH; Brunicardi FC
Pancreas; 2007 Oct; 35(3):199-206. PubMed ID: 17895838
[TBL] [Abstract][Full Text] [Related]
10. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.
Efrat S; Fusco-DeMane D; Lemberg H; al Emran O; Wang X
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3576-80. PubMed ID: 7724601
[TBL] [Abstract][Full Text] [Related]
11. Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.
Levine DS; Sanchez CA; Rabinovitch PS; Reid BJ
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6427-31. PubMed ID: 1650467
[TBL] [Abstract][Full Text] [Related]
12. Proliferation, senescence, and neoplastic progression of beta cells in hyperplasic pancreatic islets.
Teitelman G; Alpert S; Hanahan D
Cell; 1988 Jan; 52(1):97-105. PubMed ID: 2894250
[TBL] [Abstract][Full Text] [Related]
13. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.
Teitz T; Chang JC; Kitamura M; Yen TS; Kan YW
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2910-4. PubMed ID: 7681991
[TBL] [Abstract][Full Text] [Related]
14. The Rip1Tag2 Transgenic Mouse Model.
Bill R; Christofori G
Methods Mol Biol; 2016; 1464():151-161. PubMed ID: 27858364
[TBL] [Abstract][Full Text] [Related]
15. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
Müller-Hermelink N; Braumüller H; Pichler B; Wieder T; Mailhammer R; Schaak K; Ghoreschi K; Yazdi A; Haubner R; Sander CA; Mocikat R; Schwaiger M; Förster I; Huss R; Weber WA; Kneilling M; Röcken M
Cancer Cell; 2008 Jun; 13(6):507-18. PubMed ID: 18538734
[TBL] [Abstract][Full Text] [Related]
16. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in transgenic models of multistep carcinogenesis.
D' Angelo MG; Afanasieva T; Aguzzi A
J Neurooncol; 2000; 50(1-2):89-98. PubMed ID: 11245284
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of streptozotocin on tumor development in transgenic mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Brinck-Johnsen T; Longnecker DS
Pancreas; 1991 Jul; 6(4):475-8. PubMed ID: 1678889
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes.
Ganss R; Hanahan D
Cancer Res; 1998 Oct; 58(20):4673-81. PubMed ID: 9788621
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.
Augstein P; Heinke P; Salzsieder E; Berg S; Rettig R; Salzsieder C; Harrison LC
Endocrinology; 2004 Jun; 145(6):2747-52. PubMed ID: 15033908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
